Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DASH
2018-001904-12Phase 2
- Sponsor
- University of Nottingham
- Start
- Nov 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intracerebral hemorrhage (ICH) and brain hemorrhage (ICH) comparing Desmopressin with Placebo (2 arms). Primary endpoint: Feasibility of randomisation, intervention administration, and follow-up completion.
02
Drugs
desmopressin
03
Conditions
intracerebral hemorrhage (ICH)brain hemorrhage (ICH)
Beyond the preview
Go deeper on 2018-001904-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001904-12.